Large-scale testing (Phase 3)Study completedNCT00495118
What this trial is testing
A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.
Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen, LP 314